↓ Skip to main content

Dove Medical Press

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, February 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

policy
2 policy sources

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
53 Mendeley
Title
Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
Published in
ClinicoEconomics and Outcomes Research: CEOR, February 2013
DOI 10.2147/ceor.s39492
Pubmed ID
Authors

Claudio Mencacci, Guido Di Sciascio, Pablo Katz, Claudio Ripellino

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 53 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 13%
Researcher 6 11%
Unspecified 5 9%
Student > Bachelor 5 9%
Other 4 8%
Other 12 23%
Unknown 14 26%
Readers by discipline Count As %
Medicine and Dentistry 15 28%
Psychology 7 13%
Unspecified 5 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Economics, Econometrics and Finance 4 8%
Other 4 8%
Unknown 14 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2020.
All research outputs
#5,471,255
of 25,457,858 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#118
of 525 outputs
Outputs of similar age
#54,740
of 291,605 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#2
of 7 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 525 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 291,605 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.